- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0784 - Cellules dendritiquesLeurs progéniteurs
Détention brevets de la classe C12N 5/0784
Brevets de cette classe: 1111
Historique des publications depuis 10 ans
91
|
95
|
100
|
90
|
72
|
96
|
77
|
83
|
79
|
31
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Yale University | 2356 |
22 |
Flaskworks, LLC | 38 |
20 |
Baylor Research Institute | 238 |
18 |
Transimmune AG | 22 |
17 |
The Regents of the University of California | 19803 |
16 |
Oncotherapy Science, Inc. | 279 |
14 |
Baylor College of Medicine | 938 |
12 |
University of Florida Research Foundation, Inc. | 3983 |
11 |
Northwest Biotherapeutics, Inc. | 29 |
11 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
11 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3123 |
11 |
PrimeVax Immuno-Oncology, Inc. | 14 |
10 |
Immunicum AB | 13 |
9 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
9 |
FUJIFILM Cellular Dynamics, Inc. | 138 |
9 |
Hryz (Guangzhou) Biotech Co. | 13 |
9 |
Hryz (Shanghai) Biotech Co. | 13 |
9 |
Board of Regents, The University of Texas System | 5745 |
8 |
Coimmune, Inc. | 37 |
8 |
Asgard Therapeutics AB | 14 |
8 |
Autres propriétaires | 869 |